APARINDS.NS(APARINDS.NS)
APARINDS.NS
No analyst ratings available
No analyst price targets available for APARINDS.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $282.50B | $330.79B | $395.10B | $369.50B |
| Low | $269.92B | $311.15B | $372.08B | $349.61B |
| High | $307.08B | $355.43B | $421.36B | $397.96B |
| EBITDA Avg | $23.02B | $26.96B | $32.20B | $30.11B |
| Low | $22.00B | $25.36B | $30.32B | $28.49B |
| High | $25.03B | $28.97B | $34.34B | $32.43B |
| EBIT Avg | $20.98B | $24.57B | $29.35B | $27.44B |
| Low | $20.05B | $23.11B | $27.64B | $25.97B |
| High | $22.81B | $26.40B | $31.30B | $29.56B |
| Net Income Avg | $13.86B | $15.28B | $18.75B | $15.87B |
| Low | $11.78B | $14.09B | $17.50B | $14.76B |
| High | $14.13B | $17.22B | $21.26B | $17.46B |
| EPS Avg | $328.16 | $381.42 | $477.20 | $394.50 |
| Low | $292.83 | $350.30 | $434.85 | $366.90 |
| High | $351.09 | $428.01 | $528.51 | $434.01 |
| Analysts (Rev / EPS) | 7 / 7 | 8 / 8 | 4 / 4 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $73.30B | $72.60B | $71.15B |
| Low | $73.30B | $72.60B | $71.15B |
| High | $73.30B | $72.60B | $71.15B |
| EBITDA Avg | $5.97B | $5.92B | $5.80B |
| Low | $5.97B | $5.92B | $5.80B |
| High | $5.97B | $5.92B | $5.80B |
| EBIT Avg | $5.44B | $5.39B | $5.28B |
| Low | $5.44B | $5.39B | $5.28B |
| High | $5.44B | $5.39B | $5.28B |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |